Funded Tech Companies
Presidio Pharmaceuticals
Presidio Pharmaceuticals was a leading biopharmaceutical tech company, based in San Francisco. Presidio Pharmaceuticals was purchased by BioCryst Pharmaceuticals.
Company Overview
Company Name
Presidio Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1700 Owens St. 184
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Website
Email Address
Company Background Information
Overview
Presidio is focused on developing novel and established therapeutic modalities and small molecule compounds for the treatment of HIV-1, HCV and other chronic virus infections.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/16/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Financial Officer
Leo Redmond
Chief Medical Officer
Nathaniel Brown
Chief Scientific Officer
Richard Colonno
VP - Regulatory Affairs
Eric Ruby
Company Investors
- Baker Brothers Investments (Felix Baker)
- Nexus Medical Partners
- New Leaf Venture Partners (Srinivas Akkaraju)
- Bay City Capital (Daniel Perez)
- Ventures West (Kenneth Galbraith)
- Sagamore Ventures
- Panorama Capital (Rodney Ferguson)
- Sagamore Ventures (Peter Brooks)
- Panorama Capital (Srinivas Akkaraju)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs